| Authors | Sebastian Theurich, Joke Malcher, Kerstin Wennhold, Alexander Shimabukuro-Vornhagen, Jens Chemnitz, Udo Holtick, Anke Krause, Carsten Kobe, Deniz Kahraman, Andreas Engert, Christof Scheid, Geothy Chakupurakal, Michael Hallek, Michael von Bergwelt-Baildon |
| Journal | Journal of clinical oncology : official journal of the American Society of Clinical Oncology
(J Clin Oncol)
Vol. 31
Issue 5
Pg. e59-63
(Feb 10 2013)
ISSN: 1527-7755 [Electronic] United States |
| PMID | 23269992
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
| Chemical References |
- Antineoplastic Agents
- HLA-A2 Antigen
- Immunoconjugates
- KLRB1 protein, human
- Ki-1 Antigen
- NK Cell Lectin-Like Receptor Subfamily B
- Brentuximab Vedotin
|
| Topics |
- Antineoplastic Agents
(administration & dosage, adverse effects, therapeutic use)
- Apoptosis
(immunology)
- Brentuximab Vedotin
- CD4-Positive T-Lymphocytes
(immunology)
- Combined Modality Therapy
- Drug Administration Schedule
- Graft vs Host Disease
(etiology)
- HLA-A2 Antigen
(immunology)
- Hematopoietic Stem Cell Transplantation
(adverse effects)
- Hodgkin Disease
(drug therapy, immunology, surgery, therapy)
- Humans
- Immunoconjugates
(administration & dosage, adverse effects, therapeutic use)
- Immunotherapy, Adoptive
(methods)
- Ki-1 Antigen
(antagonists & inhibitors)
- Lymphocytes
(immunology)
- NK Cell Lectin-Like Receptor Subfamily B
(immunology)
- Polyneuropathies
(chemically induced)
- Recurrence
- Remission Induction
- Shock, Septic
(etiology)
- T-Lymphocytes
(immunology)
- T-Lymphocytes, Cytotoxic
(immunology)
- Th17 Cells
(immunology)
- Thrombocytopenia
(chemically induced)
- Transplantation, Homologous
- Treatment Outcome
|
